BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tavares LP, Negreiros-Lima GL, Lima KM, E Silva PMR, Pinho V, Teixeira MM, Sousa LP. Blame the signaling: Role of cAMP for the resolution of inflammation. Pharmacol Res 2020;159:105030. [PMID: 32562817 DOI: 10.1016/j.phrs.2020.105030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Liao X, Wu C, Shao Z, Zhang S, Zou Y, Wang K, Ha Y, Xing J, Zheng A, Shen Z, Zheng S, Guo J, Jie W. SETD4 in the Proliferation, Migration, Angiogenesis, Myogenic Differentiation and Genomic Methylation of Bone Marrow Mesenchymal Stem Cells. Stem Cell Rev Rep 2021;17:1374-89. [PMID: 33506343 DOI: 10.1007/s12015-021-10121-1] [Reference Citation Analysis]
2 Abou Saleh L, Boyd A, Aragon IV, Koloteva A, Spadafora D, Mneimneh W, Barrington RA, Richter W. Ablation of PDE4B protects from Pseudomonas aeruginosa-induced acute lung injury in mice by ameliorating the cytostorm and associated hypothermia. FASEB J 2021;35:e21797. [PMID: 34383981 DOI: 10.1096/fj.202100495R] [Reference Citation Analysis]
3 Spengler K, Zibrova D, Woods A, Langendorf CG, Scott JW, Carling D, Heller R. Protein kinase A negatively regulates VEGF-induced AMPK activation by phosphorylating CaMKK2 at serine 495. Biochem J 2020;477:3453-69. [PMID: 32869834 DOI: 10.1042/BCJ20200555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Felix FB, Vago JP, Fernandes DO, Martins DG, Moreira IZ, Gonçalves WA, Costa WC, Araújo JMD, Queiroz-Junior CM, Campolina-Silva GH, Soriani FM, Sousa LP, Grespan R, Teixeira MM, Pinho V. Biochanin A Regulates Key Steps of Inflammation Resolution in a Model of Antigen-Induced Arthritis via GPR30/PKA-Dependent Mechanism. Front Pharmacol 2021;12:662308. [PMID: 33995086 DOI: 10.3389/fphar.2021.662308] [Reference Citation Analysis]
5 Kouki MA, Pritchard AB, Alder JE, Crean S. Do Periodontal Pathogens or Associated Virulence Factors Have a Deleterious Effect on the Blood-Brain Barrier, Contributing to Alzheimer's Disease? J Alzheimers Dis 2021. [PMID: 34897087 DOI: 10.3233/JAD-215103] [Reference Citation Analysis]
6 Vago JP, Amaral FA, van de Loo FAJ. Resolving inflammation by TAM receptor activation. Pharmacol Ther 2021;227:107893. [PMID: 33992683 DOI: 10.1016/j.pharmthera.2021.107893] [Reference Citation Analysis]
7 Sholokh A, Klussmann E. Local cyclic adenosine monophosphate signalling cascades-Roles and targets in chronic kidney disease. Acta Physiol (Oxf) 2021;232:e13641. [PMID: 33660401 DOI: 10.1111/apha.13641] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang B, Zhao J, Guo P, Wang Z, Xu L, Liu A, Du G. Effects of Naodesheng tablets on amyloid beta-induced dysfunction: A traditional Chinese herbal formula with novel therapeutic potential in Alzheimer's disease revealed by systems pharmacology. Biomed Pharmacother 2021;141:111916. [PMID: 34328103 DOI: 10.1016/j.biopha.2021.111916] [Reference Citation Analysis]
9 Felix FB, Vago JP, Beltrami VA, Araújo JMD, Grespan R, Teixeira MM, Pinho V. Biochanin A as a modulator of the inflammatory response: an updated overview and therapeutic potential. Pharmacol Res 2022;:106246. [PMID: 35562014 DOI: 10.1016/j.phrs.2022.106246] [Reference Citation Analysis]
10 Tavares LP, Melo EM, Sousa LP, Teixeira MM. Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7). Seminars in Immunology 2022. [DOI: 10.1016/j.smim.2022.101601] [Reference Citation Analysis]
11 Otto M, Dorn B, Grasmik T, Doll M, Meissner M, Jakob T, Hrgovic I. Apremilast effectively inhibits TNFα-induced vascular inflammation in human endothelial cells. J Eur Acad Dermatol Venereol 2021. [PMID: 34699634 DOI: 10.1111/jdv.17769] [Reference Citation Analysis]
12 Sriram K, Insel MB, Insel PA. Inhaled β2 Adrenergic Agonists and Other cAMP-Elevating Agents: Therapeutics for Alveolar Injury and Acute Respiratory Disease Syndrome? Pharmacol Rev 2021;73:488-526. [PMID: 34795026 DOI: 10.1124/pharmrev.121.000356] [Reference Citation Analysis]
13 Aslam M, Ladilov Y. Emerging Role of cAMP/AMPK Signaling. Cells 2022;11:308. [DOI: 10.3390/cells11020308] [Reference Citation Analysis]
14 Tang B, Zhu J, Zhang B, Wu F, Wang Y, Weng Q, Fang S, Zheng L, Yang Y, Qiu R, Chen M, Xu M, Zhao Z, Ji J. Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis. Front Immunol 2020;11:592084. [PMID: 33240279 DOI: 10.3389/fimmu.2020.592084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Li X, Gao J, Tao J. Purinergic Signaling in the Regulation of Gout Flare and Resolution. Front Immunol 2021;12:785425. [PMID: 34925366 DOI: 10.3389/fimmu.2021.785425] [Reference Citation Analysis]
16 Putnins EE, Goebeler V, Ostadkarampour M. Monoamine Oxidase-B Inhibitor Reduction in Pro-Inflammatory Cytokines Mediated by Inhibition of cAMP-PKA/EPAC Signaling. Front Pharmacol 2021;12:741460. [PMID: 34867348 DOI: 10.3389/fphar.2021.741460] [Reference Citation Analysis]